• Mashup Score: 6

    The Coronavirus Disease 2019 (COVID-19) pandemic has evolved over the past 3+ years, and strategies to prevent illness and treat infection have changed over time. As COVID-19 transitions from a pandemic to endemic infection, widespread non-pharmaceutical interventions such as mask mandates and governmental policies requiring social distancing have given way to more selective strategies for risk mitigation. Monoclonal antibody therapies used for disease prevention and treatment lost utility due to the emergence of resistant viral variants.

    Tweet Tweets with this article
    • In Press! #COVID19 #Treatments: Then and Now https://t.co/SkpXxSXo8a

  • Mashup Score: 0

    Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care

    Tweet Tweets with this article
    • Lung cancer is the leading cause of death from #cancer in the US. Oncology Times offers a vast collection of #lungcancer research, compiling new discoveries, #treatments, and drugs to combat this deadly disease. Read the latest research: https://t.co/XQYGZBoC7l https://t.co/bRmjoc7hHH

  • Mashup Score: 0

    In this Healio video exclusive, Neilanjan Nandi, MD, FACP, discusses the financial burden for patients with inflammatory bowel disease in South Asia, fueled by costly diagnostics and treatments and lack of health insurance. “Although medical insurance does exist in South Asia, the comprehensive profile that we’re used to in the West is not so comprehensive there,” Nandi,

    Tweet Tweets with this article
    • VIDEO with @FITWITMD: Costly #treatments, lack of #insurance hinder care for #IBD patients in South Asia @southasianIBD #GITwitter #MedTwitter https://t.co/vFRf32ddUk

  • Mashup Score: 0

    In this Healio video exclusive, Neilanjan Nandi, MD, FACP, discusses the financial burden for patients with inflammatory bowel disease in South Asia, fueled by costly diagnostics and treatments and lack of health insurance. “Although medical insurance does exist in South Asia, the comprehensive profile that we’re used to in the West is not so comprehensive there,” Nandi,

    Tweet Tweets with this article
    • In this @GoHealio #GI #video exclusive, @FITWITMD discusses the financial burden for #patients with #IBD in South Asia, fueled by costly diagnostics and #treatments and lack of health #insurance. @southasianIBD #GITwitter #MedTwitter https://t.co/vFRf32dLJS

  • Mashup Score: 0

    With the new year, it seemed like a good time to do some home maintenance.

    Tweet Tweets with this article
    • In this issue, we discuss setting up clinical trials in the office and examine the cost of treatments and delays in insurance coverage. Read More: https://t.co/UMGoWAXGG8 #dermtwitter #dermatology #clinicaltrials #treatments #insurancecoverage